Savior Lifetec Corp.
4167
Rank in Stocks
#16867
Savior Lifetec Corporation, a specialty injectable company, develops, produces,... Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan.
Share Price
$0.57463205
Last synced: 2026-11-10
Market Cap
$190.52M
Change (1 day)
-0.53%
Change (1 year)
5.95%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Savior Lifetec Corp. (4167)
Category
Healthcare
Earnings for Savior Lifetec Corp. (4167)
Earnings in Jun 2026 TTM: $32.14M
According to Savior Lifetec Corp.'s latest financial reports, its current earnings (TTM) are $32.14M. In 2025 the company earned $17.02M, an increase over its 2024 earnings of $5.47M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Savior Lifetec Corp. from 2011 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $32.14M | 88.85% |
| 2025 | $17.02M | 211.33% |
| 2024 | $5.47M | 509.00% |
| 2023 | $897.52K | -24.21% |
| 2022 | $1.18M | 229.67% |
| 2021 | $359.20K | -95.98% |
| 2020 | $8.93M | -5,515.31% |
| 2019 | $-164.95K | -98.60% |
| 2018 | $-11.76M | -1,665.70% |
| 2017 | $750.94K | -111.73% |
| 2016 | $-6.40M | -57.32% |
| 2015 | $-15.00M | 33.72% |
| 2014 | $-11.22M | 46.51% |
| 2013 | $-7.66M | -50.88% |
| 2012 | $-15.59M | 101.29% |
| 2011 | $-7.74M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $4.76B | 14,709.92% |
US
|
|
| $-2.73B | -8,591.70% |
US
|
|
| $-4.02B | -12,597.01% |
AU
|
|
| $2.83B | 8,692.98% |
BE
|
|
| $1.50B | 4,557.97% |
NL
|
Questions about Savior Lifetec Corp.'s net income
What is Savior Lifetec Corp.'s net income?
Savior Lifetec Corp.'s net income over the last twelve months is $32.14M, as of Jun 2026.
What was Savior Lifetec Corp.'s net income in 2025?
In 2025, Savior Lifetec Corp.'s net income was $17.02M, 211.33% more than in 2024 ($5.47M).
How has Savior Lifetec Corp.'s net income changed since 2020?
From 2020 to 2025, Savior Lifetec Corp.'s net income went from $8.93M to $17.02M, an average growth of 13.76% a year.
How does Savior Lifetec Corp.'s net income compare with similar companies?
Savior Lifetec Corp.'s net income ($32.14M) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $4.76B.